Squarepoint’s Zevra Therapeutics ZVRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.7M Sell
182,864
-134,202
-42% -$1.21M ﹤0.01% 2312
2025
Q4
$2.84M Buy
317,066
+48,989
+18% +$463K 0.01% 1835
2025
Q3
$2.55M Buy
+268,077
New +$2.69M 0.01% 1904
2025
Q2
Sell
-68,050
Closed -$510K 5240
2025
Q1
$510K Buy
68,050
+51,516
+312% +$409K ﹤0.01% 3285
2024
Q4
$138K Buy
16,534
+4,384
+36% +$37.4K ﹤0.01% 4606
2024
Q3
$84.3K Buy
+12,150
New +$82.5K ﹤0.01% 3905
2024
Q2
Sell
-22,332
Closed -$130K 4849
2024
Q1
$130K Sell
22,332
-776
-3% -$4.77K ﹤0.01% 3737
2023
Q4
$151K Buy
23,108
+3,930
+20% +$18.4K ﹤0.01% 3675
2023
Q3
$92.4K Buy
19,178
+467
+2% +$2.33K ﹤0.01% 3569
2023
Q2
$95.4K Sell
18,711
-1,546
-8% -$8.33K ﹤0.01% 3371
2023
Q1
$111K Buy
+20,257
New +$107K ﹤0.01% 2952
2022
Q1
Sell
-10,202
Closed -$89K 3663
2021
Q4
$89K Buy
+10,202
New +$91K ﹤0.01% 2945
2021
Q2
Sell
-26,206
Closed -$241K 3783
2021
Q1
$241K Buy
+26,206
New +$229K ﹤0.01% 2572

Other funds holding ZVRA